{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:51:45Z","timestamp":1782309105133,"version":"3.54.5"},"reference-count":254,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Current knowledge on the renin\u2013angiotensin system (RAS) indicates its central role in the pathogenesis of cardiovascular remodelling via both hemodynamic alterations and direct growth and the proliferation effects of angiotensin II or aldosterone resulting in the hypertrophy of cardiomyocytes, the proliferation of fibroblasts, and inflammatory immune cell activation. The noncoding regulatory microRNAs has recently emerged as a completely novel approach to the study of the RAS. A growing number of microRNAs serve as mediators and\/or regulators of RAS-induced cardiac remodelling by directly targeting RAS enzymes, receptors, signalling molecules, or inhibitors of signalling pathways. Specifically, microRNAs that directly modulate pro-hypertrophic, pro-fibrotic and pro-inflammatory signalling initiated by angiotensin II receptor type 1 (AT1R) stimulation are of particular relevance in mediating the cardiovascular effects of the RAS. The aim of this review is to summarize the current knowledge in the field that is still in the early stage of preclinical investigation with occasionally conflicting reports. Understanding the big picture of microRNAs not only aids in the improved understanding of cardiac response to injury but also leads to better therapeutic strategies utilizing microRNAs as biomarkers, therapeutic agents and pharmacological targets<\/jats:p>","DOI":"10.3390\/ijms22094762","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T05:10:55Z","timestamp":1619759455000},"page":"4762","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The Impact of microRNAs in Renin\u2013Angiotensin-System-Induced Cardiac Remodelling"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-9735","authenticated-orcid":false,"given":"Michaela","family":"Adamcova","sequence":"first","affiliation":[{"name":"Department of Physiology, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Simkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Simkova 870, 500 03 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9922-4885","authenticated-orcid":false,"given":"Fedor","family":"Simko","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia"},{"name":"3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, 83305 Bratislava, Slovakia"},{"name":"Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, 84505 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"ref_1","unstructured":"Goodman, L.S., Brunton, L.L., Chabner, B., and Knollmann, B.C. (2011). Goodman & Gilman\u2019s Pharmacological Basis of Therapeutics, McGraw-Hill."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10557-012-6424-y","article-title":"RAAS inhibitors and cardiovascular protection in large scale trials","volume":"27","author":"Krum","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"703175:1","DOI":"10.1155\/2014\/703175","article-title":"Hypertension and cardiovascular remodelling in rats exposed to continuous light: Protection by ACE-inhibition and melatonin","volume":"2014","author":"Simko","year":"2014","journal-title":"Mediators Inflamm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2015.04.092","article-title":"Effects of captopril, spironolactone, and simvastatin on the cardiovascular system of non-diseased Wistar rats","volume":"190","author":"Simko","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Simko, F., Pechanova, O., Repova, K., Aziriova, S., Krajcirovicova, K., Celec, P., Tothova, L., Vrankova, S., Balazova, L., and Zorad, S. (2017). Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081612"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Simko, F., Baka, T., Poglitsch, M., Repova, K., Aziriova, S., Krajcirovicova, K., Zorad, S., Adamcova, M., and Paulis, L. (2018). Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103017"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Simko, F., Hrenak, J., Adamcova, M., and Paulis, L. (2021). Renin-Angiotensin-Aldosterone System: Friend or Foe\u2014The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063217"},{"key":"ref_8","first-page":"111","article-title":"Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications","volume":"1","author":"Singh","year":"2016","journal-title":"J. Cell. Signal."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.RES.86.12.1266","article-title":"Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: Molecular mechanisms","volume":"86","author":"Lorenzo","year":"2000","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.89.5.2273","article-title":"Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat","volume":"89","author":"Schieffer","year":"1994","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/01.hjh.0000358830.95439.e8","article-title":"Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats","volume":"27","author":"Simko","year":"2009","journal-title":"J. Hypertens. Suppl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1074\/jbc.M105253200","article-title":"The angiotensin II AT2 receptor is an AT1 receptor antagonist","volume":"276","author":"AbdAlla","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.2174\/1381612811319170012","article-title":"Non-ACE pathway-induced angiotensin II production","volume":"19","author":"Uehara","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1026215712983","article-title":"ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: Pathophysiological consideration of the unresolved battle","volume":"17","author":"Simko","year":"2003","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hrenak, J., and Simko, F. (2020). Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218038"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.HYP.30.3.535","article-title":"Counterregulatory actions of angiotensin-(1-7)","volume":"30","author":"Ferrario","year":"1997","journal-title":"Hypertension"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","article-title":"Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis","volume":"93","author":"Santos","year":"2008","journal-title":"Exp. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/01.HYP.0000196268.08909.fb","article-title":"Angiotensin-converting enzyme 2 and angiotensin-(1-7): An evolving story in cardiovascular regulation","volume":"47","author":"Ferrario","year":"2006","journal-title":"Hypertension"},{"key":"ref_24","first-page":"125","article-title":"Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy","volume":"3","author":"Schindler","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/01.HYP.0000160325.59323.b8","article-title":"Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats","volume":"45","author":"Walters","year":"2005","journal-title":"Hypertension"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.116.07572","article-title":"G-Protein-Coupled Receptor MrgD Is a Receptor for Angiotensin-(1-7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase A","volume":"68","author":"Tetzner","year":"2016","journal-title":"Hypertension"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fmed.2019.00107","article-title":"Alamandine and Its Receptor MrgD Pair Up to Join the Protective Arm of the Renin-Angiotensin System","volume":"6","author":"Schleifenbaum","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Riquelme","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.ATV.0000253889.09765.5f","article-title":"Mass-spectrometric identification of a novel angiotensin peptide in human plasma","volume":"27","author":"Jankowski","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1096\/fj.11-185470","article-title":"Angioprotectin: An angiotensin II-like peptide causing vasodilatory effects","volume":"25","author":"Jankowski","year":"2011","journal-title":"FASEB J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"48623","DOI":"10.1074\/jbc.C100512200","article-title":"Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase","volume":"276","author":"Albiston","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0361-9230(93)90297-O","article-title":"Angiotensin II(3-8) (ANG IV) hippocampal binding: Potential role in the facilitation of memory","volume":"32","author":"Wright","year":"1993","journal-title":"Brain Res. Bull."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.2174\/1381612821666150909093927","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain","volume":"21","author":"Hrenak","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"896861","DOI":"10.1155\/2015\/896861","article-title":"The ACE2\/Apelin Signaling, MicroRNAs, and Hypertension","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Hypertens."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2013.09.001","article-title":"Apelin and its receptor APJ in cardiovascular diseases","volume":"428","author":"Yu","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fphys.2018.00557","article-title":"The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer","volume":"9","author":"Wysocka","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"ref_38","first-page":"1","article-title":"Heart failure and angiotensin converting enzyme inhibition: Problems and perspectives","volume":"48","author":"Simko","year":"1999","journal-title":"Physiol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1113\/expphysiol.2007.040030","article-title":"Prorenin and (pro)renin receptor: A review of available data from in vitro studies and experimental models in rodents","volume":"93","author":"Nguyen","year":"2008","journal-title":"Exp. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1582-4934.2011.01377.x","article-title":"Regulation of the (pro)renin-renin receptor in cardiac remodelling","volume":"16","author":"Mahmud","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41581-019-0160-5","article-title":"The (pro)renin receptor in health and disease","volume":"15","author":"Ichihara","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Nehme, A., Zouein, F.A., Zayeri, Z.D., and Zibara, K. (2019). An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology. J. Cardiovasc. Dev. Dis., 6.","DOI":"10.3390\/jcdd6020014"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00391.2007","article-title":"High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes","volume":"293","author":"Singh","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tem.2007.05.001","article-title":"The intracellular renin-angiotensin system: A new paradigm","volume":"18","author":"Kumar","year":"2007","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11906-009-0020-y","article-title":"The intracellular renin-angiotensin system in the heart","volume":"11","author":"Kumar","year":"2009","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"H1675","DOI":"10.1152\/ajpheart.91493.2007","article-title":"Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: Role in extracellular matrix production","volume":"294","author":"Singh","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/db08-0805","article-title":"Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis","volume":"57","author":"Singh","year":"2008","journal-title":"Diabetes"},{"key":"ref_48","first-page":"62","article-title":"Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment","volume":"106","author":"Azevedo","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac Fibrosis: The Fibroblast Awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1172\/JCI117243","article-title":"Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression","volume":"93","author":"Crabos","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1161\/01.CIR.96.11.3954","article-title":"Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism","volume":"96","author":"Ohkubo","year":"1997","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1172\/JCI10037","article-title":"Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload","volume":"106","author":"Senbonmatsu","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.7150\/ijbs.28103","article-title":"Cardiac fibrosis: New insights into the pathogenesis","volume":"14","author":"Ma","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI316","article-title":"Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell","volume":"101","author":"Leri","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/me.2004-0536","article-title":"Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II","volume":"20","author":"Hunyady","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1152\/japplphysiol.01383.2010","article-title":"Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes","volume":"111","author":"Lunde","year":"2011","journal-title":"J. Appl. Physiol. (1985)"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrg2504","article-title":"Small silencing RNAs: An expanding universe","volume":"10","author":"Ghildiyal","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1064703","article-title":"siRNAs can function as miRNAs","volume":"17","author":"Doench","year":"2003","journal-title":"Genes Dev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.110.227496","article-title":"The art of microRNA research","volume":"108","year":"2011","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The Potential for microRNA Therapeutics and Clinical Research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1278436","DOI":"10.1155\/2017\/1278436","article-title":"MicroRNA as a Therapeutic Target in Cardiac Remodeling","volume":"2017","author":"Chen","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/jhh.2013.97","article-title":"Renin-sensitive microRNAs correlate with atherosclerosis plaque progression","volume":"28","author":"Deiuliis","year":"2014","journal-title":"J. Hum. Hypertens."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MNH.0000000000000440","article-title":"Role of microRNAs in aldosterone signaling","volume":"27","author":"Butterworth","year":"2018","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"111115","DOI":"10.1016\/j.mce.2020.111115","article-title":"Non-coding RNAs and the mineralocorticoid receptor in the kidney","volume":"521","author":"Butterworth","year":"2021","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: Signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/CIRCULATIONAHA.112.109256","article-title":"G(13)-mediated signaling pathway is required for pressure overload-induced cardiac remodeling and heart failure","volume":"126","author":"Takefuji","year":"2012","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev-pharmtox-070115-095427","article-title":"Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System","volume":"56","author":"Forrester","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2741\/3923","article-title":"Angiotensin II induces inflammation leading to cardiac remodeling","volume":"17","author":"Jia","year":"2012","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: New roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.34.1.118","article-title":"Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells","volume":"34","author":"Funakoshi","year":"1999","journal-title":"Hypertension"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.111.173328","article-title":"Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage","volume":"59","author":"Zhang","year":"2012","journal-title":"Hypertension"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000248135.97380.76","article-title":"Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism","volume":"48","author":"Luther","year":"2006","journal-title":"Hypertension"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Sriramula, S., and Francis, J. (2015). Tumor Necrosis Factor-Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138372"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: The effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J. Hum. Hypertens."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/hc0302.103712","article-title":"Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice","volume":"105","author":"Bendall","year":"2002","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jacc.2015.05.020","article-title":"Contractile Function During Angiotensin-II Activation: Increased Nox2 Activity Modulates Cardiac Calcium Handling via Phospholamban Phosphorylation","volume":"66","author":"Zhang","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NF\u03baB signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jcmm.12687","article-title":"Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress","volume":"20","author":"Lin","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.yjmcc.2015.11.004","article-title":"Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy","volume":"89","author":"Kishore","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M708218200","article-title":"B-cell receptor activation induces BIC\/miR-155 expression through a conserved AP-1 element","volume":"283","author":"Yin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.12.009","article-title":"Regulation of the MIR155 host gene in physiological and pathological processes","volume":"532","author":"Elton","year":"2013","journal-title":"Gene"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1098\/rstb.2008.0209","article-title":"Shhh! Silencing by microRNA-155","volume":"364","author":"Teng","year":"2009","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCULATIONAHA.112.001357","article-title":"Macrophage microRNA-155 promotes cardiac hypertrophy and failure","volume":"128","author":"Heymans","year":"2013","journal-title":"Circulation"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/CIRCRESAHA.114.303784","article-title":"Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy","volume":"114","author":"Seok","year":"2014","journal-title":"Circ. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bbadis.2019.02.014","article-title":"Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling","volume":"1865","author":"Yuan","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"606045","DOI":"10.3389\/fimmu.2020.606045","article-title":"Exosomes Derived from Hypertrophic Cardiomyocytes Induce Inflammation in Macrophages via miR-155 Mediated MAPK Pathway","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3892\/etm.2016.3506","article-title":"miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy","volume":"12","author":"Yang","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.atherosclerosis.2010.12.024","article-title":"Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration","volume":"215","author":"Zhu","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_96","first-page":"393","article-title":"microRNA-155 regulates angiotensin II type 1 receptor expression in umbilical vein endothelial cells from severely pre-eclamptic pregnant women","volume":"27","author":"Cheng","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/HYPERTENSIONAHA.112.197301","article-title":"Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase","volume":"60","author":"Sun","year":"2012","journal-title":"Hypertension"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1152\/physiolgenomics.00079.2014","article-title":"TNF-\u03b1 alters the release and transfer of microparticle-encapsulated miRNAs from endothelial cells","volume":"46","author":"Alexy","year":"2014","journal-title":"Physiol. Genom."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbrc.2010.08.067","article-title":"MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts","volume":"400","author":"Zheng","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1470320313503693","article-title":"MicroRNA-155 inhibits angiotensin II-induced vascular smooth muscle cell proliferation","volume":"15","author":"Yang","year":"2014","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Liu, X., Meng, H., Jiang, C., Yang, S., Cui, F., and Yang, P. (2016). Differential microRNA Expression and Regulation in the Rat Model of Post-Infarction Heart Failure. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160920"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.devcel.2009.10.013","article-title":"A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance","volume":"17","author":"Quiat","year":"2009","journal-title":"Dev Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2016.02.145","article-title":"MicroRNA deep sequencing reveals chamber-specific miR-208 family expression patterns in the human heart","volume":"211","author":"Kakimoto","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice","volume":"119","author":"Callis","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","article-title":"Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure","volume":"124","author":"Montgomery","year":"2011","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.apjtm.2015.07.023","article-title":"Effect of microRNA-208a on mitochondrial apoptosis of cardiomyocytes of neonatal rats","volume":"8","author":"Meng","year":"2015","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"597032","DOI":"10.1155\/2015\/597032","article-title":"MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction","volume":"2015","author":"Tony","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.12659\/MSM.908096","article-title":"Ghrelin Alleviates Angiotensin II-Induced H9c2 Apoptosis: Impact of the miR-208 Family","volume":"24","author":"Wang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.2174\/1381612822666160210143047","article-title":"MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK)","volume":"22","author":"Huang","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"F943","DOI":"10.1152\/ajprenal.00183.2015","article-title":"MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injury","volume":"309","author":"Rana","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1476-5381.2011.01375.x","article-title":"Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes","volume":"164","author":"Jeppesen","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncomms2090","article-title":"The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy","volume":"3","author":"Ucar","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"11190","DOI":"10.3390\/ijms140611190","article-title":"Angiotensin II regulates microRNA-132\/-212 in hypertensive rats and humans","volume":"14","author":"Eskildsen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1177\/1470320314539367","article-title":"The microRNA-132\/212 family fine-tunes multiple targets in Angiotensin II signalling in cardiac fibroblasts","volume":"16","author":"Eskildsen","year":"2015","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical development of a miR-132 inhibitor for heart failure treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2007.061170","article-title":"MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy","volume":"170","author":"Cheng","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/cvr\/cvv026","article-title":"miR-21: A star player in cardiac hypertrophy","volume":"105","author":"Duygu","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Clark, A.L., Maruyama, S., Sano, S., Accorsi, A., Girgenrath, M., Walsh, K., and Naya, F.J. (2016). miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151515"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/BJ20130833","article-title":"The miR-19a\/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1","volume":"457","author":"Song","year":"2014","journal-title":"Biochem. J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41467-019-09530-1","article-title":"Therapeutic role of miR-19a\/19b in cardiac regeneration and protection from myocardial infarction","volume":"10","author":"Gao","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000355429","article-title":"Downregulation of microRNA-19b contributes to angiotensin II-induced overexpression of connective tissue growth factor in cardiomyocytes","volume":"127","author":"Gao","year":"2014","journal-title":"Cardiology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/HJH.0000000000001769","article-title":"MicroRNA-19a\/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A","volume":"36","author":"Liu","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.omtn.2020.01.017","article-title":"MicroRNA-20b Promotes Cardiac Hypertrophy by the Inhibition of Mitofusin 2-Mediated Inter-organelle Ca2+ Cross-Talk","volume":"19","author":"Qiu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/cvr\/cvt151","article-title":"Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling","volume":"99","author":"Wei","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_125","first-page":"975","article-title":"MicroRNA-20b-5p promotes ventricular remodeling by targeting the TGF-\u03b2\/Smad signaling pathway in a rat model of ischemia-reperfusion injury","volume":"42","author":"Liang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cvr\/cvu254","article-title":"miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8","volume":"105","author":"Yan","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3892\/mmr.2016.5574","article-title":"MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI70577","article-title":"Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy","volume":"124","author":"Bang","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/jcmm.12445","article-title":"Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy","volume":"19","author":"Huang","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/CIRCRESAHA.110.228437","article-title":"Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98\/let-7","volume":"108","author":"Yang","year":"2011","journal-title":"Circ. Res."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Pan, W., Zhong, Y., Cheng, C., Liu, B., Wang, L., Li, A., Xiong, L., and Liu, S. (2013). MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053950"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Huang, J., Sun, W., Huang, H., Ye, J., Pan, W., Zhong, Y., Cheng, C., You, X., Liu, B., and Xiong, L. (2014). miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094382"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/0963689719843806","article-title":"MicroRNA-133a and Myocardial Infarction","volume":"28","author":"Xiao","year":"2019","journal-title":"Cell Transplant."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Leptidis, S., El Azzouzi, H., Lok, S.I., de Weger, R., Olieslagers, S., Olieslagers, S., Kisters, N., Silva, G.J., Heymans, S., and Cuppen, E. (2013). A deep sequencing approach to uncover the miRNOME in the human heart. PLoS ONE, 8.","DOI":"10.1371\/annotation\/e33f9763-3385-42c7-b31e-d433dc8e499a"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Catalucci","year":"2007","journal-title":"Nat. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jcmm.12218","article-title":"Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes","volume":"18","author":"Chen","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.1054","article-title":"miR133a regulates cardiomyocyte hypertrophy in diabetes","volume":"26","author":"Feng","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","article-title":"MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts","volume":"106","author":"Matkovich","year":"2010","journal-title":"Circ. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","article-title":"MicroRNAs play an essential role in the development of cardiac hypertrophy","volume":"100","author":"Sayed","year":"2007","journal-title":"Circ. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCRESAHA.109.212183","article-title":"The role of microRNA-133 in cardiac hypertrophy uncovered","volume":"106","author":"Abdellatif","year":"2010","journal-title":"Circ. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1725","article-title":"The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation","volume":"38","author":"Chen","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1101\/gad.1738708","article-title":"microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart","volume":"22","author":"Liu","year":"2008","journal-title":"Genes Dev."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1242\/jcs.010728","article-title":"The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes","volume":"120","author":"Xu","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/jcp.22939","article-title":"MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension","volume":"227","author":"Castoldi","year":"2012","journal-title":"J. Cell Physiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"H1340","DOI":"10.1152\/ajpheart.00592.2009","article-title":"NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression","volume":"298","author":"Li","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"H968","DOI":"10.1152\/ajpheart.00721.2016","article-title":"A novel role for miR-133a in centrally mediated activation of the renin-angiotensin system in congestive heart failure","volume":"312","author":"Sharma","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Li, Y., Cai, X., Guan, Y., Wang, L., Wang, S., Li, Y., Fu, Y., Gao, X., and Su, G. (2016). Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1\/2 Phosphorylation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148482"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.yjmcc.2013.07.002","article-title":"Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction","volume":"63","author":"Kandadi","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/db16-0023","article-title":"Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase","volume":"65","author":"Nandi","year":"2016","journal-title":"Diabetes"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3389\/fphys.2018.01275","article-title":"MiR-133a Mimic Alleviates T1DM-Induced Systolic Dysfunction in Akita: An MRI-Based Study","volume":"9","author":"Nandi","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.3892\/mmr.2015.4441","article-title":"MicroRNA-1 suppresses cardiac hypertrophy by targeting nuclear factor of activated T cells cytoplasmic 3","volume":"12","author":"Yin","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"E9006","DOI":"10.1073\/pnas.1708772114","article-title":"Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy","volume":"114","author":"Zaglia","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1242\/jcs.067165","article-title":"Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy","volume":"123","author":"Li","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11010-015-2635-4","article-title":"CDK6 mediates the effect of attenuation of miR-1 on provoking cardiomyocyte hypertrophy","volume":"412","author":"Yuan","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.109.879429","article-title":"Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions","volume":"120","author":"Elia","year":"2009","journal-title":"Circulation"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Li, Q., Xie, J., Wang, B., Li, R., Bai, J., Ding, L., Gu, R., Wang, L., and Xu, B. (2016). Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148480"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/FJC.0000000000000203","article-title":"MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a","volume":"65","author":"Wei","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41418-020-0522-3","article-title":"Angiotensin-(1-9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p\/PKIA pathway","volume":"27","author":"Morales","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5494\/wjh.v2.i4.34","article-title":"Oxidative stress-mediated effects of angiotensin II in the cardiovascular system","volume":"2","author":"Wen","year":"2012","journal-title":"World J. Hypertens."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1074\/jbc.M114.550624","article-title":"Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome","volume":"289","author":"Bracey","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","article-title":"Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system","volume":"110","author":"Griendling","year":"2012","journal-title":"Circ. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yjmcc.2014.02.002","article-title":"Redox regulation of cardiac hypertrophy","volume":"73","author":"Sag","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000441621","article-title":"Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension","volume":"52","author":"Belo","year":"2015","journal-title":"J. Vasc. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbrc.2004.12.152","article-title":"Angiotensin II induces MMP-2 in a p47phox-dependent manner","volume":"328","author":"Luchtefeld","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/cvr\/cvr067","article-title":"Angiotensin II increases periostin expression via Ras\/p38 MAPK\/CREB and ERK1\/2\/TGF-\u03b21 pathways in cardiac fibroblasts","volume":"91","author":"Li","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1089\/ars.2012.4641","article-title":"Angiotensin II, NADPH oxidase, and redox signaling in the vasculature","volume":"19","author":"Montezano","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/HYPERTENSIONAHA.107.098459","article-title":"Angiotensin II-induced extracellular signal-regulated kinase 1\/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts","volume":"51","author":"Olson","year":"2008","journal-title":"Hypertension"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","article-title":"Myofibroblasts: Trust your heart and let fate decide","volume":"70","author":"Davis","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.ATV.0000112930.40564.89","article-title":"Involvement of apoptosis signal-regulating kinase-1 on angiotensin II-induced monocyte chemoattractant protein-1 expression","volume":"24","author":"Omura","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.cellsig.2014.06.011","article-title":"A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology","volume":"26","author":"Balakumar","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yjmcc.2015.09.009","article-title":"p63RhoGEF regulates auto- and paracrine signaling in cardiac fibroblasts","volume":"88","author":"Ongherth","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1038\/ncomms11455","article-title":"RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jcp.25210","article-title":"The Nox1\/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4","volume":"231","author":"Somanna","year":"2016","journal-title":"J. Cell Physiol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: A perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.RES.84.9.1073","article-title":"Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms","volume":"84","author":"Moriguchi","year":"1999","journal-title":"Circ. Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jcmm.12763","article-title":"Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II","volume":"20","author":"Peng","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbrc.2015.06.101","article-title":"Cytoplasmic translocation of HuR contributes to angiotensin II induced cardiac fibrosis","volume":"463","author":"Bai","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"137823","DOI":"10.1155\/2015\/137823","article-title":"Transforming growth factor Beta family: Insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications","volume":"2015","author":"Poniatowski","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/mgme.2000.3032","article-title":"Induction of cardiac fibrosis by transforming growth factor-beta(1)","volume":"71","author":"Lijnen","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1096\/fj.00-0827fje","article-title":"Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes","volume":"15","author":"Wenzel","year":"2001","journal-title":"FASEB J."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","article-title":"Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism","volume":"111","author":"Esteban","year":"2005","journal-title":"Circulation"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cardiores.2007.02.008","article-title":"TGF-beta signaling in vascular fibrosis","volume":"74","author":"Carvajal","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.RES.0000218782.52610.dc","article-title":"Essential role of Smad3 in angiotensin II-induced vascular fibrosis","volume":"98","author":"Wang","year":"2006","journal-title":"Circ. Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"H3020","DOI":"10.1152\/ajpheart.2000.279.6.H3020","article-title":"Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro","volume":"279","author":"Hao","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ki.2008.213","article-title":"Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation","volume":"74","author":"Carvajal","year":"2008","journal-title":"Kidney Int."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Seoane","year":"2005","journal-title":"Genes Dev."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/01.ASN.0000014252.37680.E4","article-title":"Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation","volume":"13","author":"Li","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"H1282","DOI":"10.1152\/ajpheart.00910.2006","article-title":"Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts","volume":"293","author":"Wang","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1681\/ASN.2009121244","article-title":"Smad2 protects against TGF-beta\/Smad3-mediated renal fibrosis","volume":"21","author":"Meng","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/75037","article-title":"TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat. Med."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"22771","DOI":"10.1074\/jbc.272.36.22771","article-title":"Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction","volume":"272","author":"Wang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cvr\/cvp015","article-title":"MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue","volume":"82","author":"Roy","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3892\/mmr.2016.4834","article-title":"Regulatory roles of microRNA-21 in fibrosis through interaction with diverse pathways (Review)","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the pathogenesis of atrial fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cellsig.2014.01.005","article-title":"Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration","volume":"26","author":"Siddesha","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/eurheartj\/ehv109","article-title":"Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis","volume":"36","author":"Lorenzen","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1681\/ASN.2010111168","article-title":"Smad3-mediated upregulation of miR-21 promotes renal fibrosis","volume":"22","author":"Zhong","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.bbadis.2015.04.006","article-title":"p-SMAD2\/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling","volume":"1852","author":"Nistal","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/mmr.2014.2312","article-title":"MicroRNA-21 inhibits SMAD7 expression through a target sequence in the 3\u2032 untranslated region and inhibits proliferation of renal tubular epithelial cells","volume":"10","author":"Lin","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1159\/000479995","article-title":"Mir-21 Promotes Cardiac Fibrosis after Myocardial Infarction Via Targeting Smad7","volume":"42","author":"Yuan","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/carcin\/bgr246","article-title":"MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF\u03b2R2) in colon cancer cells","volume":"33","author":"Yu","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/ATVBAHA.111.234286","article-title":"Transforming growth factor-\u03b2-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21","volume":"32","author":"Kumarswamy","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"14369","DOI":"10.1038\/s41598-017-13305-3","article-title":"Mir-21 Mediates the Inhibitory Effect of Ang (1-7) on AngII-induced NLRP3 Inflammasome Activation by Targeting Spry1 in lung fibroblasts","volume":"7","author":"Sun","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.7150\/thno.15007","article-title":"Crucial Role of miR-433 in Regulating Cardiac Fibrosis","volume":"6","author":"Tao","year":"2016","journal-title":"Theranostics"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jcmm.12754","article-title":"MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13","volume":"20","author":"Zhou","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.peptides.2018.05.008","article-title":"MiR-503 suppresses hypoxia-induced proliferation, migration and angiogenesis of endothelial progenitor cells by targeting Apelin","volume":"105","author":"Wen","year":"2018","journal-title":"Peptides"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.reth.2019.12.002","article-title":"miR-503\/Apelin-12 mediates high glucose-induced microvascular endothelial cells injury via JNK and p38MAPK signaling pathway","volume":"14","author":"Chen","year":"2020","journal-title":"Regen. Ther."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCRESAHA.113.301209","article-title":"Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction","volume":"113","author":"Matsumoto","year":"2013","journal-title":"Circ. Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"17615","DOI":"10.1073\/pnas.1206432109","article-title":"Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function","volume":"109","author":"Bernardo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a regulates cardiac ageing and function","volume":"495","author":"Boon","year":"2013","journal-title":"Nature"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.taap.2014.10.006","article-title":"Early biomarkers of doxorubicin-induced heart injury in a mouse model","volume":"281","author":"Desai","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"62312","DOI":"10.18632\/oncotarget.11468","article-title":"MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat","volume":"7","author":"Piegari","year":"2016","journal-title":"Oncotarget"},{"key":"ref_224","first-page":"1355","article-title":"MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4","volume":"18","author":"Huang","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.3892\/mmr.2017.7584","article-title":"Inhibition of microRNA-155 ameliorates cardiac fibrosis in the process of angiotensin II-induced cardiac remodeling","volume":"16","author":"Wei","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/jcb.25935","article-title":"The Role of c-SKI in Regulation of TGF\u03b2-Induced Human Cardiac Fibroblast Proliferation and ECM Protein Expression","volume":"118","author":"Wang","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Eissa, M.G., and Artlett, C.M. (2019). The MicroRNA miR-155 Is Essential in Fibrosis. Noncoding RNA, 5.","DOI":"10.3390\/ncrna5010023"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/jcp.24296","article-title":"NF-\u03baB mediated miR-26a regulation in cardiac fibrosis","volume":"228","author":"Wei","year":"2013","journal-title":"J. Cell Physiol."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Angelini, A., Li, Z., Mericskay, M., and Decaux, J.F. (2015). Regulation of Connective Tissue Growth Factor and Cardiac Fibrosis by an SRF\/MicroRNA-133a Axis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139858"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"24747","DOI":"10.1038\/srep24747","article-title":"Autophagy inhibition of hsa-miR-19a-3p\/19b-3p by targeting TGF-\u03b2 R II during TGF-\u03b21-induced fibrogenesis in human cardiac fibroblasts","volume":"6","author":"Zou","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13046-017-0602-5","article-title":"miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: Validation by bioinformatics and experimental analyses","volume":"36","author":"Jiang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7150\/ijbs.23230","article-title":"The role of TGF-\u03b2\/SMAD4 signaling in cancer","volume":"14","author":"Zhao","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/HYPERTENSIONAHA.109.144428","article-title":"Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes","volume":"55","author":"Liu","year":"2010","journal-title":"Hypertension"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"Sutherland","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.15252\/emmm.201303604","article-title":"MicroRNA mimicry blocks pulmonary fibrosis","volume":"6","author":"Montgomery","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mt.2014.25","article-title":"miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-\u03b2\/Smad3 signaling","volume":"22","author":"Zhang","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1159\/000453187","article-title":"MiR-22 may Suppress Fibrogenesis by Targeting TGF\u03b2R I in Cardiac Fibroblasts","volume":"40","author":"Hong","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.115.05548","article-title":"MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis","volume":"66","author":"Wang","year":"2015","journal-title":"Hypertension"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.111.180729","article-title":"Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs","volume":"58","author":"Marques","year":"2011","journal-title":"Hypertension"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/HYPERTENSIONAHA.113.01701","article-title":"A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH\/2J genetically hypertensive mice","volume":"62","author":"Jackson","year":"2013","journal-title":"Hypertension"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41440-020-0453-x","article-title":"Neural suppression of miRNA-181a in the kidney elevates renin expression and exacerbates hypertension in Schlager mice","volume":"43","author":"Jackson","year":"2020","journal-title":"Hypertens. Res."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/CS20140417","article-title":"Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: Results from prospective and randomized study of treatment with renin-angiotensin system blockade","volume":"128","author":"Satoh","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1101\/gad.1842409","article-title":"MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury","volume":"23","author":"Xin","year":"2009","journal-title":"Genes Dev."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/cdd.2009.153","article-title":"The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease","volume":"16","author":"Elia","year":"2009","journal-title":"Cell Death Differ."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1172\/JCI38864","article-title":"Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster","volume":"119","author":"Boettger","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1933719109351935","article-title":"Brain renin-angiotensin system: Fetal epigenetic programming by maternal protein restriction during pregnancy","volume":"17","author":"Goyal","year":"2010","journal-title":"Reprod. Sci."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Hu, B., Song, J.T., Qu, H.Y., Bi, C.L., Huang, X.Z., Liu, X.X., and Zhang, M. (2014). Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1\/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096338"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/jhh.2013.117","article-title":"Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: Novel targets in essential hypertension","volume":"28","author":"Kontaraki","year":"2014","journal-title":"J. Hum. Hypertens."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20130420","article-title":"Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421","volume":"127","author":"Lambert","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.carpath.2014.05.006","article-title":"Contribution of renin-angiotensin system to exercise-induced attenuation of aortic remodeling and improvement of endothelial function in spontaneously hypertensive rats","volume":"23","author":"Gu","year":"2014","journal-title":"Cardiovasc. Pathol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yjmcc.2014.06.008","article-title":"Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system","volume":"75","author":"Kemp","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1152\/physiolgenomics.00084.2014","article-title":"Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expression","volume":"46","author":"Maharjan","year":"2014","journal-title":"Physiol. Genom."},{"key":"ref_254","first-page":"4055","article-title":"microRNA-125b contributes to high glucose-induced reactive oxygen species generation and apoptosis in HK-2 renal tubular epithelial cells by targeting angiotensin-converting enzyme 2","volume":"20","author":"Huang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4762\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:55:53Z","timestamp":1760162153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":254,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22094762"],"URL":"https:\/\/doi.org\/10.3390\/ijms22094762","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]}}}